Skip to main content
 

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions

AHA Innovators’ Network Member Company was granted an unique dual clearance from the FDA for the AI detection of
life-threatening cardiac conditions, including heart attacks.

Learn more here.

More News

  • Ken Nelson Joins Epitel’s Board of Directors

  • Learnroll joins Innovators’ Network at American Heart Association’s Center for Health Technology & Innovation

  • AHA Innovators’ Network Member AliveCor receives unique Dual FDA clearance of AI that can detect life-threatening cardiac conditions